source
- Assertio rejects Garda bid, accepts Zydus offer valuing company at $23.50 per shareAssertio Holdings announced it has terminated its pending acquisition by Garda Therapeutics after the board approved a higher offer from another suitor. The new proposal from Zydus Worldwide value…
- Takeda plans to cut 4,500 jobs, about 9% of workforce, under new CEO's restructuring planTakeda announced it will eliminate roughly 9% of its global workforce, affecting about 4,500 positions, over the coming fiscal year. The cuts are part of a restructuring effort that began under th…